Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

SNP genetic polymorphisms of MDR-1, CYP1A2 and CYPB11 genes in four canine breeds upon toxicological evaluation

Gagliardi , Llambi S, Arruga MV

The fields of pharmacogenetics and pharmacogenomics have become increasingly promising regarding the clinical application of genetic data to aid in prevention of adverse reactions. Specific screening tests can predict which...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Future Trends of Helicobacter pylori Eradication Therapy in Korea

Lee JY, Kim N

The prevalence of Helicobacter pylori infection in Korea shows a decreasing trend and has changed to that of developed country, especially for those below 30 years old. However, the primary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer

Cerne JZ, Pohar-Perme M, Novakovic , Frkovic-Grazio S, Stegel V, Gersak K

OBJECTIVE: Estrogen plays a key role in breast cancer development and functionally relevant genetic variants within the estrogen metabolic pathway are prime candidates for a possible association with breast cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prodrug-activating Gene Therapy with Rabbit Cytochrome P450 4B1/4-Ipomeanol or 2-Aminoanthracene System in Glioma Cells

Jang SJ, Kang JH, Lee TS, Kim SJ, Kim KI, Lee YJ, Cheon GJ, Choi CW, Lim SM

  • KMID: 1455395
  • Nucl Med Mol Imaging.
  • 2010 Sep;44(3):193-198.
OBJECTIVE: We determined the cytotoxic properties of cytochrome P450 4B1 (CYP4B1) activated 4-ipomeanol (4-ipo) and 2-aminoanthracene (2-AA) in rat glioma to verify the CYP4B1/4-ipo or 2-AA system for prodrug-activating gene...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Intolerance to Warfarin Dosing in an Intermediate Metabolizer of CYP2C9

Lee SY, Kim JS, Kim JW

  • KMID: 2428302
  • Yonsei Med J.
  • 2005 Dec;46(6):843-846.
We report a case of intolerance to warfarin dosing due to impaired drug metabolism in a patient heterozygous for the CYP2C9*3 allele. A 30-year-old woman with an artificial cardiac pacemaker...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case Report of a Patient Carrying CYP2C9*3/4 Genotype with Extremely Low Warfarin Dose Requirement

Lee SY, Nam MH, Kim JS, Kim JW

We report a case of intolerance to warfarin dosing due to impaired drug metabolism in a patient with CYP2C9*3/*4. A 73-yr-old woman with atrial fibrilation was taking warfarin. She attained...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cytochrome P450 2C19 Polymorphism is Associated with Reduced Clopidogrel Response in Cerebrovascular Disease

Lee JB, Lee KA, Lee KY

PURPOSE: Clopidogrel is a prodrug that requires transformation into an active metabolite by cytochrome P450 (CYP) in the liver in order to irreversibly inhibit the P2Y12 adenosine diphosphate platelet receptor....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of CYP2C19*2 and *3 Genetic Variants with Essential Hypertension in Koreans

Shin DJ, Kwon J, Park AR, Bae Y, Shin ES, Park S, Jang Y

PURPOSE: The cytochrome P450 2C19 (CYP2C19) metabolizes arachidonic acid to produce epoxyicosanoid acids, which are involved in vascular tone and regulation of blood pressure. Recent findings suggest that CYP2C19 gene...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of CYP2C19 Polymorphism and Helicobacter pylori Status on the Antisecretory Effect of Omeprazole in Gastroesophageal Reflux Disease

Sohn YH, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ

  • KMID: 782759
  • Korean J Gastroenterol.
  • 2006 Sep;48(3):162-171.
BACKGROUND/AIMS: The acid suppressive effect of omeprazole (OMP) is influenced by the metabolic capacity of gastric acid suppression, which is dependent on CYP2C19 polymorphism. The aim of this study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Triple Therapy with Rabeprazole for Helicobacter pylori Infection in relation to CYP2C19 Genotype

Lee SB, Park SJ, Ryu JK, Lee JK, Kim HJ, Bae JS, Jung HS, Park SM

  • KMID: 1066037
  • Korean J Gastroenterol.
  • 2003 Dec;42(6):468-475.
BACKGROUND/AIMS: Genetic polymorphism of cytochrome P450 CYP2C19 influences the efficacy of proton pump inhibitor (PPI) in Helicobacter pylori (H. pylori) eradication therapy. We investigated the difference in the cure...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical, Pharmacokinetic, and Pharmacogenetic Determinants of Clopidogrel Resistance in Korean Patients with Acute Coronary Syndrome

Park KJ, Chung HS, Kim SR, Kim HJ, Han JY, Lee SY

BACKGROUND: Clopidogrel has been widely used to prevent recurrent ischemia in patients with acute coronary syndrome (ACS). However, inter-individual variability in response to clopidogrel has been a problem in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr